Form 4: Mind Medicine (MindMed) Inc. Director Gryska Acquires Stock Options
SEC Form 4 Filing
Director David W. Gryska acquired stock options for 16,506 common shares of Mind Medicine (MindMed) Inc. on June 10, 2024.
Summary
- On June 10, 2024, David W. Gryska, a director of Mind Medicine (MindMed) Inc., acquired stock options for 16,506 common shares.
- The exercise price of the stock options is $7.25.
- The options vest in monthly installments, with full vesting by June 9, 2034, or earlier if the company's annual meeting occurs before the first anniversary of the grant date.
- Following the transaction, Gryska directly owns 16,506 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Positives
- The acquisition of stock options by a director may signal confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. It's common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of stock option acquisition |
| 06/09/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.